Literature DB >> 32196612

MiR-429-5p attenuates the migration and invasion of malignant melanoma by targeting LIMK1.

H Sheng1, Y-H Guo, D-S Cao, X-J Li, Y Zhao, H Ding, Y-L Zhang, Z-H Chen.   

Abstract

OBJECTIVE: To investigate the potential effects of microRNA-429-5p (miR-429-5p) on the development of malignant melanoma (MM) and the relevant mechanism. PATIENTS AND METHODS: Quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) was used to detect the differential expression of miR-429-5p in MM tissues. The relationship between miR-429-5p expression and clinical pathological data of MM patients was analyzed. LIM kinase 1 (LIMK1) was verified as a downstream target of miR-429-5p by online prediction software, and the interaction between LIMK1 and miR-429-5p was verified by Dual-Luciferase reporter assay.
RESULTS: Compared with normal skin tissues, miR-429-5p was downregulated in MM tissues. MiR-429-5p expression was correlated with tumor size and stage of MM. Upregulation of miR-429-5p significantly inhibited protein expression of LIMK1 and reduced migration and invasion ability of MM cells. LIMK1 was involved in MM progression regulated by miR-429-5p.
CONCLUSIONS: MiR-429-5p attenuates migration and invasion in MM by targeting LIMK1. Hence, miR-429-5p/LIMK1 axis might be a potential therapeutic target for the treatment of MM.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32196612     DOI: 10.26355/eurrev_202003_20531

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  7 in total

1.  LIMK1 nuclear translocation promotes hepatocellular carcinoma progression by increasing p-ERK nuclear shuttling and by activating c-Myc signalling upon EGF stimulation.

Authors:  Zhihua Pan; Chaoqun Liu; Yunfei Zhi; Zhiyue Xie; Ling Wu; Muhong Jiang; Yujie Zhang; Rui Zhou; Liang Zhao
Journal:  Oncogene       Date:  2021-03-08       Impact factor: 9.867

2.  Characterization and clustering of kinase isoform expression in metastatic melanoma.

Authors:  David O Holland; Valer Gotea; Kevin Fedkenheuer; Sushil K Jaiswal; Catherine Baugher; Hua Tan; Michael Fedkenheuer; Laura Elnitski
Journal:  PLoS Comput Biol       Date:  2022-05-13       Impact factor: 4.779

3.  MiR-145 suppresses the motility of prostate cancer cells by targeting cadherin-2.

Authors:  Huixuan Zeng; Yishan Huang; Qiuling Liu; Hongjiao Liu; Tianzhu Long; Cairong Zhu; Xiaoping Wu
Journal:  Mol Cell Biochem       Date:  2021-05-27       Impact factor: 3.396

Review 4.  MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets.

Authors:  Soudeh Ghafouri-Fard; Mahdi Gholipour; Mohammad Taheri
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

Review 5.  Exploring the role of non-coding RNAs in autophagy.

Authors:  Soudeh Ghafouri-Fard; Hamed Shoorei; Mahdi Mohaqiq; Jamal Majidpoor; Mohammad Amin Moosavi; Mohammad Taheri
Journal:  Autophagy       Date:  2021-02-18       Impact factor: 13.391

Review 6.  The role of miR-200 family in the regulation of hallmarks of cancer.

Authors:  Klaudia Klicka; Tomasz M Grzywa; Aleksandra Mielniczuk; Alicja Klinke; Paweł K Włodarski
Journal:  Front Oncol       Date:  2022-09-08       Impact factor: 5.738

7.  Circular RNA circRNA_0082835 promotes progression and lymphatic metastasis of primary melanoma by sponging microRNA miRNA-429.

Authors:  Yute Sun; Zuoqiong Hou; Binlin Luo; Chujun Li; Jinfang Liu; Jianlan Liu; Jian Tang; Gang Yao
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.